Matt McEnanyFellow, Health and Global Policy Institute
Mr. Matt McEnany holds a Master of Public Health in Epidemiology with a Certificate in Global Health from Columbia University. While attending Columbia, he was posted for half a year at a World Health Organization (WHO) Collaborating Center, the Shanghai Mental Health Center, where he researched drug abuse in the People’s Republic of China and worked to support the localization and validation of the 11th Revision of the International Classification of Diseases (ICD-11). Following that, Mr. McEnany worked for New Jersey-based Genesis Research LLC, where he served as Senior Epidemiologist primarily in charge of post-market pharmacoepidemiologic studies dealing with mental health disorders and DEA Schedule II/III prescription drugs. Mr. McEnany is an expert in Big Data healthcare research, with experience planning and executing studies including as many as 100+ million patients across dozens of US and international databases. He also has over ten years of experience working in communications in the public sector, creating mainly press materials for Japanese central government ministries, United Nations agencies, and multinational pharmaceutical companies. Mr. McEnany joined HGPI in 2018. He is responsible for the Institute’s work on antimicrobial resistance and emerging healthcare innovations.